Trials / Recruiting
RecruitingNCT05361694
Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions
Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions (TRANSFORMM)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- University of Miami · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The key aim of the study is to define the two biologically and clinically distinct entities: progressive versus stable myeloma precursor conditions.
Conditions
Timeline
- Start date
- 2022-04-12
- Primary completion
- 2027-07-01
- Completion
- 2027-07-01
- First posted
- 2022-05-05
- Last updated
- 2026-04-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05361694. Inclusion in this directory is not an endorsement.